Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Not marketing materials
All patients should schedule a thorough consultation with their healthcare provider to review their complete medical history, current medications, and weight loss goals
For most people taking GLP-1-based therapies including retatrutide gastrointestinal symptoms tend to be most pronounced during the early weeks of treatment and during periods of dose escalation
The most important unknowns (cardiovascular safety, evidence on hard kidney outcomes, head-to-head tirals etc) all report between now and 2028
US$ 26.16
US$ 27.77
US$ 25.49
